BACKGROUND: The infection caused by the coronavirus SARS-CoV-2, is associated with an unusual pattern of organ damage in comparison to other viral-induced pathologies. A theory of autoimmunity induced by ACE-2/SARS-CoV-2 spike protein complex or its degradation products, was proposed as a possible explanation for the versatile and multiorgan damage in COVID-19.METHODS: A total of patients with COVID-19 and controls (free of COVID-19) were included. Patients were divided into two groups: patients with severe disease (30 patients admitted at the intensive care), and patients with milder clinical presentation that remained in the general therapeutical department (N.=31). The plasma levels of IL-6 and auto-antibodies against AT1R or ETAR in peripheral blood were measured and compared between COVID-19 patients with severe and milder disease and age matched controls. Clinical and standard laboratory parameters were also collected and their association with the research biomarkers was analyzed.RESULTS: Auto-antibodies against AT1R were significantly increased in severe disease course (median 19.60 U/mL, IQR 4.8-34.75) compared to milder disease (median 10.95 U/mL, IQR 7.69-17.67, P=0.017) and the control group (median 6.79 U/mL, IQR 5.10-14.05, P<0.001). ETAR antibody titers were also significantly increased in severe disease (median 14.52, IQR 6.76-32.94), compared to milder disease course (median 8.73 U/mL, IQR 6.59-13.45, P=0.023) and to the control group (median 6.64, IQR 6.79-17.92, P<0.001). The same was the trend regarding IL-6 antibodies. Severe disease (median 12.11 U/mL, IQR 5.59-19.38); milder disease (median 8.64 U/mL, IQR 1.84-14.13, P=0.039); control group (median 4.28 U/mL, IQR 0.11-1.43, P<0.001). Both AT1R and ETAR correlated to IL-6 plasma levels.CONCLUSIONS: In conclusion, we established the presence of AT1R and ETAR autoantibodies in COVID19 patients. They correlated to IL-6 plasma levels (systemic inflammation) and are associated with severe form of the disease.
No takes yet. Share an insight, caveat, or question.
Cherneva et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: